Log In
BCIQ
Print this Print this
 

CD30

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting CD30

BCIQ
Print ChartPrint this
Marketed, 1 Phase III, 1 Phase II, 2 Phase II, 1 Phase I/II, 1 Phase I, 1 Preclinical, 1
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase IIPhase IIIMarketed
Autoimmune

-

-

-

1

-

-

Cancer

1

1

1

2

1

1




 Products Targeting CD30
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

5

$296.3M

$61.9M

$230.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today